BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33057610)

  • 21. HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
    Wookey VB; Appiah AK; Kallam A; Ernani V; Smith LM; Ganti AK
    Anticancer Res; 2019 Apr; 39(4):1907-1914. PubMed ID: 30952732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis.
    Fonsêca TC; Jural LA; Marañón-Vásquez GA; Magno MB; Roza ALOC; Ferreira DMTP; Maia LC; Romañach MJ; Agostini M; Abrahão AC
    Clin Oral Investig; 2023 Dec; 28(1):62. PubMed ID: 38158517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
    Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
    Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.
    Sinha P; Karadaghy OA; Doering MM; Tuuli MG; Jackson RS; Haughey BH
    Oral Oncol; 2018 Nov; 86():121-131. PubMed ID: 30409292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of high-risk human papillomavirus mRNA silver in situ hybridization diagnostic assay in oropharyngeal squamous cell carcinomas.
    Gale N; Poljak M; Volavšek M; Hošnjak L; Velkavrh D; Bolha L; Komloš KF; Strojan P; Aničin A; Zidar N
    Pathol Res Pract; 2021 Oct; 226():153585. PubMed ID: 34455364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
    Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
    Front Immunol; 2021; 12():645170. PubMed ID: 33897693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of HPV-Associated Squamous Cell Carcinoma of the Head and Neck: Impact of Race and Socioeconomic Status.
    Pike LRG; Royce TJ; Mahal AR; Kim DW; Hwang WL; Mahal BA; Sanford NN
    J Natl Compr Canc Netw; 2020 Feb; 18(2):177-184. PubMed ID: 32023531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study.
    Barlow J; Gilja S; Ferrandino RM; Berger MH; Posner MR; Bakst RL; Khan MN; Teng MS; Genden EM; Chai RL; Roof SA
    Am J Otolaryngol; 2024; 45(3):104243. PubMed ID: 38442460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
    Balk M; Rupp R; Sievert M; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Eckstein M; Iro H; Hecht M; Gostian AO
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5489-5497. PubMed ID: 37505261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic Review of Second Primary Oropharyngeal Cancers in Patients With p16+ Oropharyngeal Cancer.
    Bollig CA; Lee DS; Mazul AL; Stepan K; Puram SV; Massa ST; Zenga J; Faden DL; Doering MM; Jackson RS; Pipkorn P
    Otolaryngol Head Neck Surg; 2021 Apr; 164(4):733-740. PubMed ID: 32928026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Snietura M; Brewczynski A; Kopec A; Rutkowski T
    Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study.
    Lorenzatti Hiles G; Chang KP; Bellile EL; Wang CI; Yen WC; Goudsmit CM; Briggs HL; Thomas TB; Peters L; Afsari MA; Pinatti LM; Morris AC; Jawad N; Carey TE; Walline HM
    PLoS One; 2021; 16(4):e0250530. PubMed ID: 33891627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.
    Payabvash S; Chan A; Jabehdar Maralani P; Malhotra A
    Neuroradiol J; 2019 Aug; 32(4):232-240. PubMed ID: 31084347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prognostic Value of Human Papilloma Virus Infection in Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis.
    Christianto S; Li KY; Huang TH; Su YX
    Laryngoscope; 2022 Sep; 132(9):1760-1770. PubMed ID: 34953144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The relationship between human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: a meta analysis].
    Yuanyuan X; Suling H; Quan Z; Shixun Z; Yucheng Y; Houyong K; Guohua H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 50(3):236-43. PubMed ID: 26268498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.
    Dale OT; Aleksic T; Shah KA; Han C; Mehanna H; Rapozo DC; Sheard JD; Goodyear P; Upile NS; Robinson M; Jones TM; Winter S; Macaulay VM
    Carcinogenesis; 2015 Jun; 36(6):648-55. PubMed ID: 25896444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.